Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05239884 · ClinicalTrials.gov registry record · NA
CSD201202: A Study to Assess Nicotine Uptake From Electronic Nicotine Delivery System P12
A NA study of Smoking and Tobacco Use, sponsored by RAI Services Company.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT05239884 is a NA study of Smoking and Tobacco Use that has completed, run by RAI Services Company. The registered enrollment target is 36 participants, below the 455-participant average among 123 other Smoking trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05239884, a NA study of Smoking and Tobacco Use, has completed, sponsored by RAI Services Company.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an open-label, randomized, 8-way crossover study designed to evaluate plasma nicotine pharmacokinetic (PK) parameters following an ad libitum use of Electronic Nicotine Delivery System (ENDS) investigational products (IPs) in a confinement setting by generally healthy combustible cigarette (CC) smokers and dual users of CC and ENDS.
Conditions Studied
Interventions
- OTHER ENDS Product A with 1.5% nicotine
- OTHER ENDS Product B with 1.5% nicotine
- OTHER ENDS Product C with 1.5% nicotine
- OTHER ENDS Product D with 1.5% nicotine
- OTHER ENDS Product E with 1.5% nicotine
Study Locations (1)
North Carolina
- High Point Clinical Trials Center - High Point
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2022-03-14 |
| Est. Completion | 2022-04-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05239884
The ClinicalTrials.gov registry entry for NCT05239884 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 455-participant average among 123 other Smoking trials with a reported enrollment target (92% lower). The listed sponsor is RAI Services Company, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Smoking appearing as the primary indexed condition, and to 5 interventions - of which ENDS Product A with 1.5% nicotine is the first listed.
NCT05239884 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT05239884 about?
NCT05239884 is a clinical study titled "CSD201202: A Study to Assess Nicotine Uptake From Electronic Nicotine Delivery System P12". This is an open-label, randomized, 8-way crossover study designed to evaluate plasma nicotine pharmacokinetic (PK) parameters following an ad libitum use of Electronic Nicotine Delivery System (ENDS) investigational products (IPs) in a confinement setting by generally healthy combustible cigarette (...
What is the current status of trial NCT05239884?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2022-03-14. Estimated completion is 2022-04-15.
What conditions does trial NCT05239884 study?
This clinical trial studies the following conditions: Smoking, Tobacco Use.
What interventions are being tested in trial NCT05239884?
The interventions under investigation include: ENDS Product A with 1.5% nicotine (OTHER), ENDS Product B with 1.5% nicotine (OTHER), ENDS Product C with 1.5% nicotine (OTHER), ENDS Product D with 1.5% nicotine (OTHER), ENDS Product E with 1.5% nicotine (OTHER).
Who is sponsoring clinical trial NCT05239884?
This trial is sponsored by RAI Services Company, which has 42 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05239884 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Alternatives for Reducing Harm Using E-cigarettes
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Enhancing Motivation to Quit Smoking Via Self-Help Intervention Targeted to Cancer Type
RECRUITING · NA
-
Personalized Tobacco Treatment in Primary Care (MOTIVATE)
RECRUITING · NA
-
Take A Break - Rural
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.